Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Mucositis 1Intra-abdominal Cancer 1Breast Neoplasms 1

Interventions

Cisplatin 4angiotensin I (1-7) 3Radiotherapy 3Radiation 3Injections 3Water 2RRx-001 2Interleukin 1 Receptor Antagonist Protein 2Drug Therapy 2Amifostine 2tempol 1peppermint oil 1pegfilgrastim 1kang-lai-te 1hydrated silica gel-based toothpaste 1golotimod 1glucarpidase 1fish oil triglycerides 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Vaccinium myrtillus extract 1Tramadol 1Therapeutics 1Surgical Procedures, Operative 1Sorbic Acid 1Sodium Bicarbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Mucositis × Tramadol × Clear all
NCT04752384 2025-04-20

Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients

Medical College of Wisconsin

Phase 2 Completed
20 enrolled 10 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡